Gainers
- Redhill Biopharma RDHL shares rose 207.0% to $0.97 during Monday's regular session. The company's market cap stands at $10.7 million.
- Biodexa Pharmaceuticals BDRX stock rose 119.89% to $6.13. The company's market cap stands at $4.2 million.
- Tharimmune THAR shares moved upwards by 27.3% to $3.66. The market value of their outstanding shares is at $2.5 million.
- Lexaria Bioscience LEXX stock rose 24.42% to $1.63. The company's market cap stands at $15.8 million.
- Mira Pharmaceuticals MIRA stock increased by 21.06% to $3.96. The market value of their outstanding shares is at $58.5 million.
- Abeona Therapeutics ABEO stock rose 19.02% to $5.13. The market value of their outstanding shares is at $126.7 million.
Losers
- Harpoon Therapeutics HARP shares decreased by 25.1% to $8.96 during Monday's regular session. The company's market cap stands at $151.6 million.
- Telesis Bio TBIO stock fell 21.24% to $0.32. The company's market cap stands at $9.5 million.
- Altamira Therapeutics CYTO shares decreased by 19.09% to $0.23. The company's market cap stands at $1.8 million.
- Universe Pharmaceuticals UPC stock fell 17.21% to $0.86. The market value of their outstanding shares is at $3.1 million.
- Kazia Therapeutics KZIA shares fell 14.29% to $0.6. The market value of their outstanding shares is at $14.1 million.
- UpHealth UPH stock fell 14.1% to $0.52. The market value of their outstanding shares is at $8.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BDRXBiodexa Pharmaceuticals PLC
$4.066.28%
CYTOALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW
$0.2620-12.7%
KZIAKazia Therapeutics Ltd
$2.97-%
LEXXLexaria Bioscience Corp
$2.16-1.79%
MIRAMira Pharmaceuticals Inc
$1.093.77%
RDHLRedhill Biopharma Ltd
$6.32-%
TBIOTelesis Bio Inc
$0.480014.3%
THARTharimmune Inc
$2.06-1.44%
UPCUniverse Pharmaceuticals Inc
$0.63901.40%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in